Skip to main content
Top
Published in: BMC Medicine 1/2018

Open Access 01-12-2018 | Research article

Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis

Authors: Mina Bakhit, Tammy Hoffmann, Anna Mae Scott, Elaine Beller, John Rathbone, Chris Del Mar

Published in: BMC Medicine | Issue 1/2018

Login to get access

Abstract

Background

Antibiotic resistance is an urgent global problem, but reversibility is poorly understood. We examined the development and decay of bacterial resistance in community patients after antibiotic use.

Methods

This was a systematic review and meta-analysis. PubMed, EMBASE and CENTRAL (from inception to May 2017) were searched, with forward and backward citation searches of the identified studies. We contacted authors whose data were unclear, and of abstract-only reports, for further information. We considered controlled or times-series studies of patients in the community who were given antibiotics and where the subsequent prevalence of resistant bacteria was measured. Two authors extracted risk of bias and data. The meta-analysis used a fixed-effects model.

Results

Of 24,492 articles screened, five controlled and 20 time-series studies (total 16,353 children and 1461 adults) were eligible.
Resistance in Streptococcus pneumoniae initially increased fourfold after penicillin-class antibiotic exposure [odds ratio (OR) 4.2, 95% confidence interval (CI) 3.5–5.4], but this fell after 1 month (OR 1.7, 95% CI 1.3–2.1). After cephalosporin-class antibiotics, resistance increased (OR 2.2, 95%CI 1.7-2.9); and fell to (OR 1.6, 95% CI 1.2-2.3) at 1 month. After macrolide-class antibiotics, resistance increased (OR 3.8, 95% CI 1.9–7.6) and persisted for 1 month (OR 5.2, 95% CI 2.6–10.3) and 3 months (OR 8.1, 95% CI 4.6–14.2, from controlled studies and OR 2.3, 95% CI 0.6–9.4, from time-series studies).
Resistance in Haemophilus influenzae after penicillins was not significantly increased (OR 1.3, 95% CI 0.9–1.9) initially but was at 1 month (OR 3.4, 95% CI 1.5–7.6), falling after 3 months (OR 1.0, 95% CI 0.5–2.2). Data were sparse for cephalosporins and macrolides.
Resistance in Enterobacter increased post-exposure (OR 3.2, 95% CI 0.9–10.8, from controlled studies and OR 7.1, 95% CI 4.2–12, from time-series studies], but was lower after 1 month (OR 1.8, 95% CI 0.9–3.6).

Conclusions

Resistance generally increased soon after antibiotic use. For some antibiotic classes and bacteria, it partially diminished after 1 and 3 months, but longer-term data are lacking and urgently needed.

Trial registration

PROSPERO CRD42015025499.
Appendix
Available only for authorised users
Literature
1.
go back to reference Joklik WK. The story of penicillin: the view from Oxford in the early 1950s. FASEB J. 1996;10(4):525–8.CrossRefPubMed Joklik WK. The story of penicillin: the view from Oxford in the early 1950s. FASEB J. 1996;10(4):525–8.CrossRefPubMed
4.
go back to reference Zaffiri L, Gardner J, Toledo-Pereyra LH. History of antibiotics. From salvarsan to cephalosporins. J Investig Surg. 2012;25(2):67–77.CrossRef Zaffiri L, Gardner J, Toledo-Pereyra LH. History of antibiotics. From salvarsan to cephalosporins. J Investig Surg. 2012;25(2):67–77.CrossRef
5.
go back to reference Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol. 2004;2(1):73–8.CrossRefPubMed Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol. 2004;2(1):73–8.CrossRefPubMed
6.
go back to reference Del Mar C, Glasziou P, Lowe JB, van Driel ML, Hoffmann T, Beller E. Addressing antibiotic resistance - focusing on acute respiratory infections in primary care. Aust Fam Physician. 2012;41(11):839–40.PubMed Del Mar C, Glasziou P, Lowe JB, van Driel ML, Hoffmann T, Beller E. Addressing antibiotic resistance - focusing on acute respiratory infections in primary care. Aust Fam Physician. 2012;41(11):839–40.PubMed
7.
go back to reference WHO. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014. WHO. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.
9.
go back to reference WHO. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016-2017. Geneva: World Health Organization; 2017. WHO. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2016-2017. Geneva: World Health Organization; 2017.
10.
go back to reference Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;6(6):CD000247. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;6(6):CD000247.
11.
go back to reference Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2014;3(3):CD000245. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2014;3(3):CD000245.
12.
go back to reference Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013;11(11):CD000023. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013;11(11):CD000023.
13.
go back to reference Venekamp RP, Sanders S, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2013;1(1):CD000219. Venekamp RP, Sanders S, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2013;1(1):CD000219.
14.
go back to reference Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW Jr, Makela M. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev. 2014;2(2):CD000243. Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW Jr, Makela M. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev. 2014;2(2):CD000243.
15.
go back to reference McCullough AR, Rathbone J, Parekh S, Hoffmann TC, Del Mar CB. Not in my backyard: a systematic review of clinicians’ knowledge and beliefs about antibiotic resistance. J Antimicrob Chemother. 2015;70(9):2465–73.CrossRefPubMed McCullough AR, Rathbone J, Parekh S, Hoffmann TC, Del Mar CB. Not in my backyard: a systematic review of clinicians’ knowledge and beliefs about antibiotic resistance. J Antimicrob Chemother. 2015;70(9):2465–73.CrossRefPubMed
16.
go back to reference Tonkin-Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. J Antimicrob Chemother. 2011;66(10):2215–23.CrossRefPubMed Tonkin-Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. J Antimicrob Chemother. 2011;66(10):2215–23.CrossRefPubMed
17.
go back to reference Arroll B, Goodyear-Smith F, Thomas DR, Kerse N. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? J Fam Pract. 2002;51(11):954–9.PubMed Arroll B, Goodyear-Smith F, Thomas DR, Kerse N. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? J Fam Pract. 2002;51(11):954–9.PubMed
18.
go back to reference Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.CrossRefPubMedPubMedCentral Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.CrossRefPubMedPubMedCentral
19.
go back to reference Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.CrossRefPubMed Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.CrossRefPubMed
20.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral
22.
go back to reference Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
23.
go back to reference Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRefPubMedPubMedCentral Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRefPubMedPubMedCentral
25.
go back to reference Berg HF, Tjhie JH, Scheffer GJ, Peeters MF, van Keulen PH, Kluytmans JA, Stobberingh EE. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. Antimicrob Agents Chemother. 2004;48(11):4183–8.CrossRefPubMedPubMedCentral Berg HF, Tjhie JH, Scheffer GJ, Peeters MF, van Keulen PH, Kluytmans JA, Stobberingh EE. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. Antimicrob Agents Chemother. 2004;48(11):4183–8.CrossRefPubMedPubMedCentral
26.
go back to reference Chern KC, Shrestha SK, Cevallos V, Dhami HL, Tiwari P, Chern L, Whitcher JP, Lietman TM. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol. 1999;83(12):1332–5.CrossRefPubMedPubMedCentral Chern KC, Shrestha SK, Cevallos V, Dhami HL, Tiwari P, Chern L, Whitcher JP, Lietman TM. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol. 1999;83(12):1332–5.CrossRefPubMedPubMedCentral
27.
go back to reference Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369(9560):482–90.CrossRefPubMed Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369(9560):482–90.CrossRefPubMed
28.
go back to reference Malhotra-Kumar S, Van Heirstraeten L, Coenen S, Lammens C, Adriaenssens N, Kowalczyk A, Godycki-Cwirko M, Bielicka Z, Hupkova H, Lannering C, et al. Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study. J Antimicrob Chemother. 2016;71(11):3258–67.CrossRefPubMed Malhotra-Kumar S, Van Heirstraeten L, Coenen S, Lammens C, Adriaenssens N, Kowalczyk A, Godycki-Cwirko M, Bielicka Z, Hupkova H, Lannering C, et al. Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study. J Antimicrob Chemother. 2016;71(11):3258–67.CrossRefPubMed
29.
go back to reference Skalet AH, Cevallos V, Ayele B, Gebre T, Zhou Z, Jorgensen JH, Zerihun M, Habte D, Assefa Y, Emerson PM, et al. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med. 2010;7(12):e1000377.CrossRefPubMedPubMedCentral Skalet AH, Cevallos V, Ayele B, Gebre T, Zhou Z, Jorgensen JH, Zerihun M, Habte D, Assefa Y, Emerson PM, et al. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med. 2010;7(12):e1000377.CrossRefPubMedPubMedCentral
30.
go back to reference Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114(6):667–70.CrossRefPubMed Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114(6):667–70.CrossRefPubMed
31.
go back to reference Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, Smith S, Crook DW, Mant D. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335(7617):429.CrossRefPubMedPubMedCentral Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, Smith S, Crook DW, Mant D. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335(7617):429.CrossRefPubMedPubMedCentral
32.
go back to reference Cohen R, Bingen E, Varon E, de La Rocque F, Brahimi N, Levy C, Boucherat M, Langue J, Geslin P. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J. 1997;16(6):555–60.CrossRefPubMed Cohen R, Bingen E, Varon E, de La Rocque F, Brahimi N, Levy C, Boucherat M, Langue J, Geslin P. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J. 1997;16(6):555–60.CrossRefPubMed
33.
go back to reference Cohen R, Navel M, Grunberg J, Boucherat M, Geslin P, Derriennic M, Pichon F, Goehrs JM. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18(5):403–9.CrossRefPubMed Cohen R, Navel M, Grunberg J, Boucherat M, Geslin P, Derriennic M, Pichon F, Goehrs JM. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18(5):403–9.CrossRefPubMed
34.
go back to reference Conradi AD, Calbo E, Cuchi E, Puig RG, Garcia-Rey C, Boada LT, Diaz-Infantes M, Martin-Herrero JE, Garau J, Spanish Pneumococcal infection Study N. Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age. Eur J Pediatr. 2007;166(5):467–71.CrossRefPubMed Conradi AD, Calbo E, Cuchi E, Puig RG, Garcia-Rey C, Boada LT, Diaz-Infantes M, Martin-Herrero JE, Garau J, Spanish Pneumococcal infection Study N. Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age. Eur J Pediatr. 2007;166(5):467–71.CrossRefPubMed
35.
go back to reference Cremieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, Mentre F, Andremont A. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments. Antimicrob Agents Chemother. 2003;47(6):2030–5.CrossRefPubMedPubMedCentral Cremieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, Mentre F, Andremont A. Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments. Antimicrob Agents Chemother. 2003;47(6):2030–5.CrossRefPubMedPubMedCentral
36.
go back to reference Dabernat H, Geslin P, Megraud F, Begue P, Boulesteix J, Dubreuil C, de La Roque F, Trinh A, Scheimberg A. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother. 1998;41(2):253–8.CrossRefPubMed Dabernat H, Geslin P, Megraud F, Begue P, Boulesteix J, Dubreuil C, de La Roque F, Trinh A, Scheimberg A. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother. 1998;41(2):253–8.CrossRefPubMed
37.
go back to reference Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J. 1998;17(10):880–5.CrossRefPubMed Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J. 1998;17(10):880–5.CrossRefPubMed
38.
go back to reference Eliasson I, Holst E, Molstad S, Kamme C. Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics. Am J Med. 1990;88(5A):51S–5S.CrossRefPubMed Eliasson I, Holst E, Molstad S, Kamme C. Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics. Am J Med. 1990;88(5A):51S–5S.CrossRefPubMed
39.
go back to reference Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, Bhatta RC, Chaudhary JS, Osaki Holm S, Whitcher JP, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005;89(9):1097–9.CrossRefPubMedPubMedCentral Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, Bhatta RC, Chaudhary JS, Osaki Holm S, Whitcher JP, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005;89(9):1097–9.CrossRefPubMedPubMedCentral
40.
go back to reference Ghaffar F, Friedland IR, Katz K, Muniz LS, Smith JL, Davis P, Reynolds J, McCracken GH Jr. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J Pediatr. 1999;135(5):618–23.CrossRefPubMed Ghaffar F, Friedland IR, Katz K, Muniz LS, Smith JL, Davis P, Reynolds J, McCracken GH Jr. Increased carriage of resistant non-pneumococcal alpha-hemolytic streptococci after antibiotic therapy. J Pediatr. 1999;135(5):618–23.CrossRefPubMed
41.
go back to reference Ghaffar F, Muniz LS, Katz K, Smith JL, Shouse T, Davis P, McCracken GH Jr. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis. 2002;34(10):1301–9.CrossRefPubMed Ghaffar F, Muniz LS, Katz K, Smith JL, Shouse T, Davis P, McCracken GH Jr. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis. 2002;34(10):1301–9.CrossRefPubMed
42.
go back to reference Huovinen P, Mattila T, Kiminki O, Pulkkinen L, Huovinen S, Koskela M, Sunila R, Toivanen P. Emergence of trimethoprim resistance in fecal flora. Antimicrob Agents Chemother. 1985;28(2):354–6.CrossRefPubMedPubMedCentral Huovinen P, Mattila T, Kiminki O, Pulkkinen L, Huovinen S, Koskela M, Sunila R, Toivanen P. Emergence of trimethoprim resistance in fecal flora. Antimicrob Agents Chemother. 1985;28(2):354–6.CrossRefPubMedPubMedCentral
43.
go back to reference Lofmark S, Jernberg C, Jansson JK, Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother. 2006;58(6):1160–7.CrossRefPubMed Lofmark S, Jernberg C, Jansson JK, Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother. 2006;58(6):1160–7.CrossRefPubMed
44.
go back to reference Morita JY, Kahn E, Thompson T, Laclaire L, Beall B, Gherardi G, O'Brien KL, Schwartz B. Impact of azithromycin on oropharyngeal carriage of group a Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 2000;19(1):41–6.CrossRefPubMed Morita JY, Kahn E, Thompson T, Laclaire L, Beall B, Gherardi G, O'Brien KL, Schwartz B. Impact of azithromycin on oropharyngeal carriage of group a Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 2000;19(1):41–6.CrossRefPubMed
45.
go back to reference Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982;306(3):130–5.CrossRefPubMed Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982;306(3):130–5.CrossRefPubMed
46.
go back to reference Nord CE, Peterson J, Ambruzs M, Fisher AC. Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults. Curr Med Res Opin. 2009;25(6):1461–7.CrossRefPubMed Nord CE, Peterson J, Ambruzs M, Fisher AC. Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults. Curr Med Res Opin. 2009;25(6):1461–7.CrossRefPubMed
47.
go back to reference Raum E, Lietzau S, von Baum H, Marre R, Brenner H. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect. 2008;14(1):41–8.CrossRefPubMed Raum E, Lietzau S, von Baum H, Marre R, Brenner H. Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect. 2008;14(1):41–8.CrossRefPubMed
48.
go back to reference Schrag SJ, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, Feris JM, Besser RE. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA. 2001;286(1):49–56.CrossRefPubMed Schrag SJ, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, Feris JM, Besser RE. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA. 2001;286(1):49–56.CrossRefPubMed
49.
go back to reference Toltzis P, Dul M, O'Riordan MA, Toltzis H, Blumer JL. Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media. Pediatr Infect Dis J. 2005;24(1):24–8.CrossRefPubMed Toltzis P, Dul M, O'Riordan MA, Toltzis H, Blumer JL. Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media. Pediatr Infect Dis J. 2005;24(1):24–8.CrossRefPubMed
50.
go back to reference Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, Navel M, Cohen R. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis. 2000;31(2):477–81.CrossRefPubMed Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, Navel M, Cohen R. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis. 2000;31(2):477–81.CrossRefPubMed
Metadata
Title
Resistance decay in individuals after antibiotic exposure in primary care: a systematic review and meta-analysis
Authors
Mina Bakhit
Tammy Hoffmann
Anna Mae Scott
Elaine Beller
John Rathbone
Chris Del Mar
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2018
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-018-1109-4

Other articles of this Issue 1/2018

BMC Medicine 1/2018 Go to the issue